I'm not sure why but some longs are even hedging on Spectral's apparent speculative Status.

Maybe they missed the news of a few weeks ago where Spectral landed the Dialysis partner deal for ARC Dialysis. The largest dialysis provider in the South Eastern US.

That deal alone is what, 4-5 times the current market cap, maybe 8-10 times. And that was Dialco's first deal with dozens more to come.

You can speculate on the brutally obvious FDA approval of PMX, but it ain't a spec stock anymore.

Spectral, or their wholly owned Dialco division more specifically, is commercialized and poised to dominate the in hospital/clinic dialysis market across North America...